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TrafﬁckingArginine-rich peptides have been used extensively as efﬁcient cellular transporters. However, gene delivery with
such peptides requires development of strategies to improve their efﬁciency. We had earlier demonstrated that
addition of small amounts of exogenous glycosaminoglycans (GAGs) like heparan sulfate or chondroitin sulfate
to different arginine-rich peptide–DNA complexes (polyplexes) led to an increase in their gene delivery efﬁciency.
This was possibly due to the formation of a ‘GAG coat’ on the polyplex surface through electrostatic interactions
which improved their extracellular stability and subsequent cellular entry. In this report, we have attempted to
elucidate the differences in intracellular processing of the chondroitin sulfate (CS)-coated polyplexes in compari-
son to the native polyplexes by using a combination of endocytic inhibitors and co-localization with endosomal
markers in various cell lines. We observed that both the native and CS-coated polyplexes are internalized by
multiple endocytic pathways although in some cell lines, the coated polyplexes are taken up primarily by caveolae
mediated endocytosis. In addition, the CS-coat improves the endosomal escape of the polyplexes as compared to
the native polyplexes. Interestingly, during these intracellular events, exogenous CS is retained with the
polyplexes until their accumulation near the nucleus. Thus we show for the ﬁrst time that exogenous GAGs in
small amounts improve intracellular routing and nuclear accumulation of arginine-based polyplexes. Therefore,
addition of exogenous GAGs is a promising strategy to enhance the transfection efﬁciency of cationic arginine-
rich peptides in multiple cell types.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Arginine-rich peptides constitute one of the most widely explored
classes of cell penetrating peptides. They have been used in delivery of
multiple types of therapeutic cargo including nucleic acids, proteins,
liposomes and nanoparticles [1–3]. Arginine-rich peptides form
complexes with plasmid DNA through electrostatic interactions and
these nano-sized polyplexes have been used for gene delivery to
different cell types in vitro and in vivo [4–8]. However, the mechanism
of internalization of these peptides is not conclusively understood,
especially when they are complexed to cargos like nucleic acids. This
impedes the development of these peptides as effective carriers of
nucleic acid therapeutics. Negatively charged cell surface molecules,
particularly the proteoglycans, have been implicated in the literature
as possible partners in the entry process of cationic cell penetrating
peptides [9–11]. However, their role in the entry (and the subsequent
intracellular events) of arginine-rich peptides complexed with cargosmics and Integrative Biology,
dia. Tel.: +91 11 29879 225;
ib.in (M. Ganguli).is ambiguous. Different factors like peptide length, sequence, arginine
content and nature of cargo seem to be important in this process. In a
previous report, we had demonstrated that 16-mer homopeptide of
arginine (R16) enters cells independent of the cell surface proteoglycans
[12]. This was true for both the free peptide as well as the peptide–DNA
complex (polyplex). Other recent reports have alsomade similar obser-
vations for arginine-rich peptides [13–15] and it is now believed that
the cell surface proteoglycans, in spite of their negative charge density,
may be dispensable for the cellular uptake of these peptides or their
complexes with cargo. It is also possible that the arginine-rich peptides
interact with the negatively chargedmembrane lipids such as phospho-
lipids for initiating their entry into the cells [16–18].
We had also reported that addition of small amounts of soluble
glycosaminoglycans (GAGs) like heparan sulfate and chondroitin
sulfate to arginine polyplexes enhanced their transfection efﬁciency
[12].We demonstrated that the exogenousGAGs used in small amounts
could improve the stability of arginine polyplexes possibly through
formation of a “GAG coat” and provide better protection of the
compacted DNA from nucleases. This resulted in higher uptake in both
the wild-type and cell surface GAG-deﬁcient Chinese hamster ovary
(CHO) cells and enhanced transfection efﬁciency as compared to the
native polyplexes. This was an unusual observation since addition of
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reported to inhibit the cell entry and cargo delivery of peptides,
polymers and liposomes [19–22]. However, it was not clear whether
in addition to the enhanced stability there were differences in the intra-
cellular processing between the native polyplexes and those coated
with GAGs and whether such differences, if any, had a role to play in
the increase in transfection efﬁciency.
In this manuscript, we report our observations on the intracellular
processing of the polyplexes of two different arginine-rich peptides in
the presence and absence of exogenous chondroitin sulfate (CS) with
an aim to delineate the role of the added GAGs in the enhancement of
transfection efﬁciency. We chose the 16-mer arginine homopeptide
(R16), and an arginine-rich peptide (32 AR; sequence (ARRRAARA)4)
which contains a heparan sulfate-bindingmotif, where the arginine res-
idues are clustered with each cluster separated by neutral alanine resi-
dues [23]. We also used different CHO cell lines with varying density
of cell surface proteoglycans to understand whether exogenous GAGs
play a universal role in enhancing transfection efﬁciency of polyplexes
made with arginine-rich peptides. We observed that irrespective of
the GAG density on the cell surface or the nature of the arginine-based
peptide used, a small amount of exogenously added CS always increases
the cellular uptake and transfection efﬁciencies of the polyplexes.
Further, we found differences in the uptake pathways between the
native polyplexes and the CS-coated polyplexes which could be playing
a role in the enhanced transfection efﬁciencies of the latter. The most
interesting conclusion in this study pertains to our observation that CS
GAGs remain associated with the polyplexes during intracellular
processing, improve their endosomal escape and aid in better accumu-
lation of the polyplexes at the nuclear periphery as compared to the na-
tive polyplexes. Thus, we show for the ﬁrst time that exogenous GAGs
(CS in particular) in small amounts confer not only extracellular stability
but also allow improved intracellular routing and localization of
arginine-based polyplexes. Such insights would not only shed light on
the role of exogenous GAGs in gene delivery by arginine-based peptides
but will also help in development of an effective strategy for efﬁcient
delivery of therapeutic nucleic acids in a wide range of cell types.
2. Experimental section
2.1. Materials
Peptides used in this studywere custom synthesized by GL Biochem
(Shanghai) Ltd (N95% purity). pMIR-REPORT™ Luciferase (Ambion)
was used for the transfection experiments and pEGFP-C1 (Clontech)
labeled with ﬂuorescein or tetramethyl rhodamine using Label IT®
Tracker kit (Mirus Bio Corporation, U.S.A.) was used for the ﬂow
cytometry and microscopy studies. Both plasmids were ampliﬁed in
Escherichia coli DH5-α and puriﬁed using GenElute HP Endotoxin-Free
Plasmid MaxiPrep Kit (Sigma).
2.2. Cell culture
Parental Chinese Hamster Ovary cells (CHO-K1) and the glycosami-
noglycan mutant cell lines pgsA-745 and pgsD-677 were maintained in
Ham's F12K medium (Sigma). All media were supplemented with 10%
(v/v) fetal bovine serum (Life Technologies, U.S.A.) and cells were kept
in a humidiﬁed 5% CO2, 37 °C incubator.
2.3. Transfection and luciferase gene expression assay
Cells were seeded in 24-well plates to achieve a conﬂuency of 70%
after 24 h. Peptide–plasmid DNA complexes (polyplexes) were
prepared at Z(+/−) of 10 with ﬁnal DNA concentration of 20 ng/μl
and incubated for 1 h at room temperature. Z(+/−) refers to charge
ratio or positive charge of peptide side chain per negative charge of
DNA phosphate. Indicated amounts of chondroitin sulfate A (Sigma)were added to the polyplexes after 30 min of incubation where re-
quired. 100 μl of polyplex (2 μg DNA/well) was added to cells in
serum free media (OptiMEM, Invitrogen). After 5 h of incubation at
37 °C, cells were replenished with 500 μl complete growth medium.
After 24 h of transfection, luciferase expression was measured as previ-
ously described [12].
For evaluating the role of endocytic pathway in the transfection efﬁ-
ciency, cells were pre-treated with the chemical inhibitors for 1 h:
chlorpromazine (5 μg/ml), genistein (200 μM), dimethylamiloride
(200 μM), cytochalasin D (20 μM) or nocodazole (20 μM) in
Opti-MEM. Cells were then incubated with the polyplexes along with
the inhibitors for 5 h at 37 °C and luciferase expression was assessed
after 24 h as mentioned above.
To assess the endosomal escape of the polyplexes, either chloro-
quine (100 μM) or baﬁlomycin A1 (100 nM)was added during the incu-
bation of cells with the polyplexes. In case of the latter, cells were
treated with baﬁlomycin A1 (100 nM) in Opti-MEM for 30 min prior
to polyplex addition.
2.4. Flow cytometry
Cells were treated with the polyplexes as described in the transfec-
tion protocol except that the plasmid was labeled with ﬂuorescein.
After 4 h of incubation with the polyplexes at 37 °C, cells were washed
twice with ice-cold phosphate-buffered saline (PBS, pH 7.4) containing
1 mg/ml heparin to remove the extracellular bound polyplex, and with
0.4% trypan blue in PBS to quench any extracellular ﬂuorescence. Cells
were collected by trypsinization and resuspended in PBS and placed
on ice. Flow cytometry measurements were carried out on Guava®
EasyCyte™ System (Guava Technologies) using CytoSoft™ software.
10,000 live cells were used for each analysis.
For evaluating the endocytic pathway, cells were pre-treated with
the chemical inhibitors for 1 h as mentioned under transfection assay.
Cells were then incubated with the polyplexes alongwith the inhibitors
for 4 h at 37 °C and processed as mentioned above.
2.5. Microscopy
Cells were seeded in 35-mm μ-dishes (ibidi, Germany) and incubat-
ed for 24 h to achieve 70–75% conﬂuency. Polyplexes at Z(+/−) 10.0
containing rhodamine labeled DNA (2 μg per dish) were added to the
cells in serum-free media (Opti-MEM) and incubated at 37 °C for 4 h.
Chondroitin sulfate, either unlabeled (Sigma) or ﬂuorescein labeled
(Cosmo Bio Co., Ltd., Japan), at the indicated concentrations, was
added to polyplexes when required. Hoechst 33342 (0.3 μg/ml,
Invitrogen) was added during the ﬁnal 30 min of incubation to stain
the cell nucleus. Cells were washed three times with ice-cold PBS(+)
containing heparin (1 mg/ml) and kept in Opti-MEM. Imaging was
done using a Nikon TiE motorized inverted ﬂuorescence microscope
equippedwith a 60×, 1.4 N.A. plan apochromat oil immersion objective.
Filter sets corresponding to DAPI (Ex330–380 nm, Em435–485 nm),
FITC (Ex465–495 nm, Em515–555 nm) and TRITC (Ex540/25 nm,
Em605/55 nm) were used. NIS viewer element (NIS-AR) software was
used for analysis of images. For co-localization with BODIPY FL C5-
lactosylceramide (Invitrogen), polyplexes were prepared as above and
incubated with the cells for either 20 min or 1 h at 37 °C.
Lactosylceramide (0.7 μM)was added alongwith the polyplexes or dur-
ing the ﬁnal 30 min of incubation respectively. Cells were washed ex-
tensively with ice cold PBS(+) containing 5% defatted BSA [24] and
heparin (1 mg/ml) respectively. For co-localization with LysoTracker
Green DND-26/LysoTracker Red DND-99 (Invitrogen), polyplexes
were incubated with cells for 2 h/4 h at 37 °C, and LysoTracker
(150 nM/350 nM) was added during the ﬁnal 5 min/30 min of incuba-
tion respectively. Cells were washed with ice-cold PBS(+) containing
heparin (1 mg/ml) and kept in Opti-MEM. Fixing was done wherever
required. Imaging was done on an inverted LSM 510 META laser
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lens. The 488nm line of an argon laserwas used to excite the endosomal
markers and 543 nmheliumneon laserwasused for rhodamine label on
DNA. Leica Confocal Microscope (Leica TCS SP5) with 60× 1.2 N.A.,
water immersion using LAS AF 2.6.0 software with ﬁlter sets: DAPI
(Ex405 nm, Em420–480 nm), FITC (Ex488, Em500–550 nm) and
LysoTracker Red (Ex532 nm, Em550–680 nm) was used for Fig. S8. For
co-localization with Alexa Fluor 488 transferrin (Invitrogen), cells
were treated with the polyplexes and transferrin (20 μg/ml) for 1.5 h
at 37 °C. Cells were then washed with ice-cold PBS(+) containing hep-
arin (1 mg/ml), followed by ice-cold acid wash buffer [24] and PBS(+).
Cells were imaged on a Nikon TiE motorized inverted ﬂuorescence
microscope equipped with a 60×, 1.4 N.A. plan apochromat oil immer-
sion objective.
Minimal processing of the microscopy images for enhancing
brightness and contrast was done using ImageJ software [25]. Pearson's
coefﬁcient and Mander's coefﬁcient for co-localization were calculated
using the JACoP plug-in [26] for ImageJ.
2.6. Immunostaining
CHO-K1 cells were seeded on 22 mm coverslip 24 h prior to the ex-
periment. At 70–80% conﬂuency, cells were treated with native R16
polyplexes or R16 polyplexes with CS at charge ratio 10 in Opti-MEM.
After 1 h of incubation, cells were washed with PBS containing heparin
(1 mg/ml) and with normal PBS twice each. Cells were ﬁxed using 4%
paraformaldehyde for 10 min at 37 °C and washed with PBS thrice for
5 min after which cells were permeabilized using 0.25% Triton-X100
for 15 min. Cells were further washed with PBS and blocked using 1%
BSA in PBS for 1 h at room temperature. Cells were then incubated
with primary antibody for clathrin (anti-clathrin heavy chain antibody
ab 21679), caveolin (anti-caveolin-1 antibody ab2910) at 1:500 dilution
for overnight at 4 °C and giantin (anti-giantin antibody ab 24586) for 2 h
at room temperature. Cells were then washed thrice with PBS contain-
ing 1% BSA for 5 min each and further incubated with secondary
antibody (Goat Anti-Rabbit) labeled with Alexa Fluor 488 (ab 150081)
at a dilution of 1:500 for 2 h. Cells were again washed thrice with PBS
containing 1% BSA and further incubated with 500 μg/ml of Hoechst
33342 solution for 10 min. Cells were again washed with PBS and
water and mounted with anti-fade mounting media. Imaging
was done on an inverted LSM 510 META laser scanning microscope
(Carl Zeiss) using a plan-apochromat 63× 1.4 N.A. lens and 405 nm,
488 nm and 543 laser lines. All antibodies used were purchased from
Abcam.
2.7. Statistical analysis
Fold change of transfection was calculated as treatment/control and
converted to log2 scale (log FC). Single sample t-test was used to
calculate signiﬁcance of difference using R software. p-Value b 0.05
was considered as statistically signiﬁcant.
3. Results
3.1. Arginine-rich peptides exhibit enhanced transfection efﬁciency and
cellular uptake in the presence of exogenous chondroitin sulfate in multiple
cell lines
We had previously observed that addition of small amounts of ex-
ogenous glycosaminoglycans (e.g. heparan sulfate (HS) and chon-
droitin sulfate (CS)) to arginine-rich polyplexes considerably
increased their transfection efﬁciency in wild-type CHO-K1 cell line
as well as the GAG-deﬁcient pgsA-745 cell line. We also showed
that the exogenous GAGs improved the stability of the polyplexes
and led to increased cellular entry [12]. In order to assess whether
the presence of exogenous GAGs enhances cellular entry andtransfection efﬁciency across different cell types with varying densi-
ty of one or more types of cell surface GAGs, we used the CHO-K1
wild-type cell line, and the CHO mutant cell lines, pgsA-745 (which
lacks all types of cell surface GAGs) and pgsD-677 (which is devoid
of cell surface HS but produces excess CS). We studied the effect of
addition of exogenous CS and HS to arginine-based polyplexes in
all the cell lines and report here the results obtained with the addi-
tion of exogenous CS only since the trend for both CS and HS is sim-
ilar. Transfection efﬁciency of native polyplexes (no added CS) and
coated polyplexes (with added CS in amounts mentioned in the ear-
lier section) prepared with R16 and 32 AR was determined using ex-
pression of the reporter gene luciferase, as shown in Fig. 1A and C. In
all the cell lines used, the transfection efﬁciency was increased at CS:
peptide w/w ratios ≤ 0.5:1. In the case of R16, CHO-K1 and pgsA-745
cells exhibited a maximum increase of an order of magnitude in
transfection efﬁciency (as reported earlier by us) whereas the
pgsD-677 cells showed nearly 6 times increment (Fig. 1A). The trans-
fection efﬁciency achieved by the commonly used commercial trans-
fection reagent Lipofectamine in the three cell lines is also shown for
comparison in Fig. 1A. On the other hand, the increase in transfection
efﬁciency of coated polyplexes containing 32 AR was 2.5–5 times
higher as compared to the native polyplexes in all the CHO cell
lines (Fig. 1C). Thus, there was an overall increase in transfection ef-
ﬁciency with low amount of exogenous CS in all the cases although
the level of increase was dependent on the cell line and composition
of the peptide. Addition of high amount of CS reduced the transfec-
tion efﬁciency in all the cases as seen earlier by us and others [12,22].
In order to assess whether CS also increased the cellular uptake of
the polyplexes, we labeled the plasmid DNA with ﬂuorescein and used
ﬂow cytometry to determine the cellular uptake of the labeled
polyplexes.We observed polyplex uptake inmore than 95% of the treat-
ed cells in all the cases after 4 h of incubation. Fig. 1B and D shows the
intracellular mean ﬂuorescence intensities of coated and native R16
and 32 AR polyplexes respectively in the cell lines used. Addition of CS
increased the total cellular uptake of both polyplexes across different
cell lines. This indicated that the presence of exogenous GAGs increased
the cellular entry of these polyplexes although the trend cannot be di-
rectly correlated to the levels of transfection efﬁciency in different cell
lines in all the cases. This has been elaborated in the Discussion section.3.2. Polyplexes of arginine homopeptide exhibit increased accumulation at
the nuclear periphery in the presence of exogenously added chondroitin
sulfate and co-localize with the chondroitin sulfate
Our next endeavor was to chart out the intracellular localization
of the native and coated polyplexes. This was ﬁrst carried out with
the R16 polyplexes. We used rhodamine-labeled plasmid DNA to pre-
pare R16 polyplexes, and added ﬂuorescein-labeled CS (as described
in the Experimental section) and observed their localization in the
different cell lines using ﬂuorescence microscopy. As seen from
Fig. 2, a larger concentration of polyplexes was present at the periph-
ery of the nucleus (stained by Hoechst) in cells treated with the CS-
containing polyplexes than in cells treated with the native
polyplexes after 4 h of incubation at 37 °C. This indicated that the ex-
ogenous CS enhanced the accumulation of the polyplexes near the
nucleus in all the three cell lines. This phenomenon was also ob-
served after only 1 h of incubation with CS-coated polyplexes,
where the GAG was un-labeled (Fig. S1 in Supplemental informa-
tion). As shown in Fig. 2, the exogenous labeled CS showed co-
localization with the plasmid DNA at the nuclear periphery (as indi-
cated by the merged yellow ﬂuorescence around the nucleus).
Pearson's coefﬁcient, a measure of co-localization, was 0.72, 0.79,
and 0.89 for the three cell lines respectively. This implied that the
CS remained associated with the polyplex during its intracellular
passage, at least up to this time point.
Fig. 1. Effect of exogenous chondroitin sulfate on cellular uptake and transfection efﬁciency of arginine-based polyplexes. A and C, R16 (A) and 32 AR (C) polyplexes at Z(+/−) 10.0 were
treated with increasing concentrations of CS (expressed as GAG:peptide w/w ratios on x-axis) and incubated with different cell lines for 5 h. Transfection efﬁciency was measured from
luciferase activity after 24 h. Light gray bars (named L in A) indicate transfection efﬁciency of Lipofectamine in the different cell lines. Values are plotted asmean± S.D. of three indepen-
dent experiments, each in duplicate (***p b 0.005, **p b 0.01, *p b 0.05). B and D, R16 (B) and 32 AR (D) polyplexes at Z(+/−) 10.0 containing ﬂuorescein-labeled plasmid DNA and those
treatedwith 0.5 and 0.3 w/w ratio of CS respectively were added to cells. After incubation for 4 h at 37 °C, cells werewashed with PBS containing heparin and trypsinized. Cellular uptake
wasmeasured using ﬂow cytometry. Mean ﬂuorescence intensities of the polyplexes in different cell lines are plotted asmean± S.D. of three independent experiments. Some of the data
points in CHO-K1 and pgsA-745 cells in A and B were taken from reference [12].
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uptake pathways
Our observations indicated enhanced cellular entry and increased
accumulation of polyplexes at the nuclear periphery in the presence of
CS, along with co-localization of polyplexes and CS in the case of R16
polyplexes. We next wanted to explore whether such increased uptake
could be because of differences in the uptake pathways in the presence
and absence of exogenous GAGs. We had shown earlier that the R16
polyplexes adopted an endocytic route of cellular entry [12]. Hence
we checked their cellular uptake in the presence of chemical inhibitors
which are known to selectively obstruct different endocytic pathways.
Clathrin-mediated endocytosis was inhibited by chlorpromazine,
which hinders clathrin-coated pit formation [27]. Caveolae-mediated
endocytosis was inhibited by genistein, a speciﬁc inhibitor of tyrosine
kinase involved in signal transduction [28,29]. Macropinocytosis was
inhibited by dimethylamiloride, which inhibits Na+/H+ ion exchange
in the plasma membrane and therefore, prevents membrane rufﬂing
[30]. In addition we also used inhibitors of the cytoskeletal network
such as cytochalasin D and nocodazole, which prevent polymerization
of actin ﬁlaments andmicrotubules respectively [31,32]. Concentrations
of these inhibitors were similar to those reported in the literature
[33,34] and caused minimum toxicity to the different cell types
(data not shown). The uptake of the polyplexes was estimated in
cells treated with the indicated inhibitors using ﬂow cytometry.
The polyplex uptake in untreated cells was taken as the control.
The results are shown in Fig. 3A.
In CHO wild-type and mutant cells, chlorpromazine did not inhibit
the uptake of the native or coated R16 polyplexes (Fig. 3A). Genistein
inhibited the uptake of both types of R16 polyplexes by 50% or more in
all cell lines. Therefore caveolae-mediated pathway may be one of the
major entry pathways of both the native arginine polyplexes and
those with exogenous CS. Dimethylamiloride, however, had different
effects on the R16 polyplexes with and without CS. The uptake of thenative polyplexes was reduced (by 40–50% in CHO-K1 and pgsA-745
and by 10% in pgsD-677) whereas in the case of the coated polyplexes,
there was either no change or an increase. This indicated that the path-
way of macropinocytosis may be operative in the case of the native R16
polyplexes, in addition to the caveolae-mediated endocytosis.
Inhibition of actin polymerization by cytochalasin D resulted in re-
duced uptake of the native polyplexes by 20–70% in the various CHO
cell lines, while the uptake of the coated polyplexeswas considerably in-
creased inmost of the cases (Fig. 3A). This was also validated by imaging
the CHO-K1 cells treated with the polyplexes, where the actin ﬁlaments
were stained with Alexa Fluor 488 phalloidin (Fig. S2 in Supplemental
information).Microtubule depolymerization by nocodazole also showed
a similar pattern, wherein the drug inhibited the uptake of the native
polyplexes by 30–70% but either enhanced or showed no inhibition in
the uptake of the polyplexes in the presence of CS in all the cell lines
(Fig. 3A).
For conﬁrming the endocytic pathway adopted by the R16 polyplexes,
we also studied their co-localization with a positive marker for caveolae-
mediated endocytosis, C5-lactosylceramide [35,36], by confocalmicrosco-
py. In thewild-type andGAG-deﬁcient CHO cell lines, both the native and
coated R16 polyplexes co-localizedwith themarker after 1 h of incubation
at 37 °C (Fig. 3B) (for R16 polyplexes Mander's coefﬁcient for fraction of
polyplex overlapping with marker was 0.437 and 0.11 in CHO-K1 and
pgs A-745 respectively and for polyplexwith exogenous CS, Mander's co-
efﬁcient for fraction of polyplex overlapping with marker was 0.837 and
0.248 in the same cell lines respectively). The results for these experi-
ments at a shorter time point of 20 min incubation are also shown in
Fig. 3C (left panel). These results indicated that a caveolae-mediated up-
take mechanism was operational in all these cases. However, co-
localization of these polyplexes with the clathrin marker, transferrin,
was also observed (Fig. 3C (right panel), Pearson's coefﬁcient 0.71). A
few of the polyplexes that entered CHO-K1 cells after 10 min incubation
also co-localized with lactosylceramide and transferrin, as shown in
Fig. S3 in Supplemental information.
Fig. 2. Localization of R16 polyplexes in the presence and absence of exogenous chondroitin sulfate. R16 polyplexes at Z(+/−) 10.0 containing rhodamine-labeled DNA, with or without
addition of ﬂuorescein-labeled chondroitin sulfate at GAG:peptide ratio of 0.5:1, were incubated with the respective cells for 4 h at 37 °C. The cell nucleus was stained with Hoechst
33342. Cells were then washed with PBS containing heparin and imaged by ﬂuorescence microscopy. Scale bar = 20 μm.
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immunostaining of clathrin and caveolin after incubation with the R16
polyplexes in CHO-K1 cells (Fig. 4). We observed that both the native
and coated R16 polyplexes partially co-localized with clathrin after 1 h
of incubation (Fig. 4A). At the same time point, co-localization was
also seen in the cells treatedwith either of the polyplexes and immuno-
stained for caveolin-1 (Fig. 4B) (for R16 polyplexes, Mander's coefﬁcient
for fraction of polyplex overlapping with clathrin and caveolin-1 was
0.206 and 0.444 respectively and for polyplexes with exogenous CS,
Mander's coefﬁcient for fraction of polyplex overlapping with clathrin
and caveolin-1 was 0.205 and 0.448).
3.4. Arginine-rich polyplexes show similar trends in cellular entry and
intracellular processing as the polyplexes of the arginine homopeptides
The experiments described in the two previous sections were
then carried out with the 32 AR polyplexes. The 32 AR polyplexes
demonstrated a pattern of cellular entry which was comparable to
that seen in case of the R16 polyplexes. As shown in Fig. 5A, the exog-
enously added CS co-localized with the 32 AR polyplex at the nuclear
periphery of CHO-K1 cells (Pearson's coefﬁcient was 0.912). Asimilar trend was also seen in the other cell lines used in this study
(data not shown). It appeared that the exogenous CS remained asso-
ciated with the polyplex and assisted their localization around the
nucleus at the time point observed.
We also elucidated the endocytic pathway adopted by the 32 AR
polyplexes in all the cell lines using the chemical inhibitors men-
tioned above. Representative results obtained for the CHO-K1 are
shown in Fig. 5B. In CHO-K1 cells, genistein signiﬁcantly inhibited
the uptake of both the native and coated 32 AR polyplexes by 80%,
while chlorpromazine and dimethylamiloride did not inhibit their
uptake. Treatment with cytochalasin D inhibited uptake of the native
polyplexes but enhanced the uptake of the coated polyplexes. This
trend was similar to what was observed for R16 polyplexes.
Nocodazole treatment also increased the uptake of the coated
polyplexes although it did not affect the uptake of the native
polyplexes in CHO-K1 cells. Similar trends were observed in the
other variants of CHO cells (data not shown).
Similar to the R16 polyplexes described in the previous section, we
observed co-localization of the 32 AR polyplexes, with and without ex-
ogenous CS, with themarkers of clathrin- and caveolae-mediated endo-
cytosis (Fig. S4 in Supplemental information).
Fig. 3. Elucidation of the endocytic pathway involved in uptake of R16 polyplexes with and without exogenous chondroitin sulfate. A, Cells were treated with the indicated endocytic in-
hibitors for 1 h prior to the addition of R16 polyplexes (with ﬂuorescein labeled DNA at Z(+/−) 10.0) with or without CS (at GAG:peptide w/w of 0.5:1). After subsequent incubation at
37 °C for 4 h, cells were washed and analyzed by ﬂow cytometry. Results are plotted as a percentage of the uptake in untreated cells. Values are given asmean± S.D. of three independent
experiments. Cpz, chlorpromazine; Gst, genistein; Dma, dimethylamiloride; CtcD, cytochalasin D; Ncd, nocodazole. B, Cells were incubated with R16 polyplexes (with rhodamine-labeled
DNA at Z(+/−) 10.0) with or without CS (at GAG:peptide w/w of 0.5:1) and incubated for 1 h at 37 °C. BODIPY FL labeled C5-lactosylceramide (0.7 μM)was added during ﬁnal 30min of
incubation. Cells were washed and imagedwith a laser scanning confocal microscope. Regions of co-localization are indicated by arrows and areas marked by a square are zoomed. Scale
bar= 10 μm. C, Cells were treated with R16 polyplexes (red) and BODIPY FL labeled C5-lactosylceramide (green), as described in B, and incubated for 20min at 37 °C or Cells were treated
with R16 polyplexes (with rhodamine-labeled DNA at Z(+/−) 10.0)with orwithout CS (at GAG:peptidew/wof 0.5:1) (red) and Alexa Fluor 488 labeled transferrin (green) and incubated
for 1.5 h at 37 °C. Cells were washed and imaged with a ﬂuorescence microscope. Some of the regions of co-localization are indicated by arrows. Scale bar = 20 μm.
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to escape the endosome
We subsequently used the R16 peptide to further decipher the intra-
cellular processing of the polyplexes with CS. We determined thetransfection efﬁciency of the R16 polyplex, with and without CS, in the
presence of the chemical inhibitors in order to correlate the endocytosis
route with the extent of gene delivery. As shown in Fig. 6A–C, treatment
with chlorpromazine increased the transfection efﬁciency of both the
native and coated R16 polyplexes in the CHO cell lines. Treatment with
Fig. 4. Colocalization of R16 polyplexes with clathrin and caveolin-1 in the presence and absence of exogenous chondroitin sulfate in CHO-K1 cells. A and B, CHO-K1 cells were treatedwith
R16 polyplexes (with rhodamine-labeled DNA at Z(+/−) 10.0)with orwithout CS (at GAG:peptidew/w of 0.5:1) (red) for 1 h at 37 °C, then ﬁxed, permeabilized and treatedwith primary
antibodies against clathrin (A) and caveolin-1(B) overnight at 4 °C. Cells were then incubatedwith Alexa Fluor 488-labeled secondary antibody for 2 h,washed and imagedwith a confocal
microscope. Scale bar = 20 μm.
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tive polyplexes considerably in the CHO cell lines, similar to what had
been observed in the uptake studies shown in Fig. 3A, indicating the
caveolar pathway as the major endocytosis route for gene delivery and
expression. Presence of dimethylamiloride showed a considerable re-
duction in transfection efﬁciency of native polyplexes in pgsD-677 cells
and amild reduction in the other cell lines. However, the transfection ef-
ﬁciency of the coated polyplexes was also mildly reduced in all the CHO
cells under similar conditions. Treatmentwith cytochalasin D resulted in
a decrease in transfection efﬁciency of both the native and coated
polyplexes by up to 10 times in the CHO cell lines. These trends are dif-
ferent from that observed in the uptake studies where both
dimethylamiloride and cytochalasin treatment caused an increase in
the uptake of the coated polyplexes and an inhibition in the case of the
native polyplexes. It is possible that the actin cytoskeleton may play a
role in the intracellular events following the uptake process in the case
of both the native and CS coated polyplexes. On the other hand,
nocodazole did not show amajor inhibition and in most cases increased
the transfection efﬁciency of the polyplexes.We have deliberated on the
possible reasons for this difference in the Discussion section.
It is thus clear that in these cell lines,multiple pathways are involved
in the uptake of the native and GAG coated polyplexes but the eventual
gene expression is also determined by the intracellular events following
the uptake process. In order to study the intracellular fate of the arginine
polyplexeswith andwithout exogenous CS after their endocytic uptake,
we assessed whether these polyplexes go to the lysosomes by co-
localization with a lysosomal marker, LysoTracker Green DND-26.
After just 2 h of incubation, the native and coated R16 polyplexesshowed co-localization with LysoTracker to a considerable extent
(Fig. 7A) (for R16 polyplexes, Mander's coefﬁcient for fraction of
polyplex overlapping with marker was 0.487 and 0.637 in CHO-K1
and pgsA-745 respectively and for polyplexes with exogenous CS,
Mander's coefﬁcient for fraction of polyplex overlapping with marker
was 0.626 and 0.458 in the same cell lines respectively). Therefore, we
next explored how the polyplexes with exogenous CS exhibit increased
transfection efﬁciency in spite of their obvious localization within the
lysosomes. For this, we estimated the transfection efﬁciency of the R16
polyplexes, with and without CS, in the presence of chloroquine and
baﬁlomycin.
Chloroquine accumulates in the endosomes due to their low pH and
causes swelling and disruption of these vesicles by osmotic effects [37].
Hence entrapped polyplexes, if any, are released into the cytosol.
Baﬁlomycin A1 is a speciﬁc inhibitor of the vacuolar type H+-ATPase,
and thus inhibits acidiﬁcation of the endosomes preventing their matu-
ration and fusion into lysosomes [38]. Any endosomal escape mecha-
nism of polyplexes that is dependent on endosomal acidiﬁcation is
therefore inhibited by baﬁlomycin treatment. Addition of chloroquine
during incubation of the polyplexes with the cells resulted in an incre-
ment, by an order of magnitude, in the transfection efﬁciency of the na-
tive R16 polyplex in the CHO cell lines (Fig. 7B). However, for the coated
polyplex, the increase was less than 1.5 times under similar conditions.
This implied that the coated polyplexes have improved ability to escape
from endosomes and are not strongly dependent on endosomal rupture
caused by chloroquine, while the native polyplexes get entrapped in the
endosomes and require chloroquine to enhance the endosomal release
and subsequent increase in transfection.
Fig. 5. Localization of 32 AR polyplexeswith andwithout exogenous chondroitin sulfate and their uptake in the presence of endocytic inhibitors. A, 32 AR polyplexes at Z (+/−) 10.0 con-
taining rhodamine-labeled DNA,with andwithoutﬂuorescein-labeled chondroitin sulfate at GAG:peptide ratio of 0.3:1, were incubatedwith CHO-K1 cells for 4 h at 37 °C. The cell nucleus
was stainedwithHoechst 33342. Cellswere thenwashedwith PBS containing heparin and imaged by ﬂuorescencemicroscopy. Scale bar=20 μm. B, Cellswere treatedwith the endocytic
inhibitors for 1 h prior to the addition of 32ARpolyplexes (withﬂuorescein labeledDNA at Z(+/−) 10.0)with orwithout CS (at GAG:peptidew/wof 0.3:1). After subsequent incubation at
37 °C for 4 h, cells were washed and analyzed by ﬂow cytometry. Results are plotted as a percentage of the uptake in untreated cells. Values are given asmean± S.D. of three independent
experiments. Cpz, chlorpromazine; Gst, genistein; Dma, dimethylamiloride; CtcD, cytochalasin D; Ncd, nocodazole.
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trafﬁc polymer–DNA complexes to the Golgi network [39,40]. In order
to checkwhether the R16 polyplexes localize to the Golgi, we performed
immunostaining of giantin, a Golgi marker, after incubation of CHO-K1
cells with R16 polyplexes for 1 h. As shown in Fig. 7C, the native R16
polyplexes exhibited very little co-localization with giantin, whereas
theCS-coatedR16 polyplexes co-localized to a larger extentwith giantin,
indicating their presence in the Golgi (Mander's coefﬁcient for native
R16 polyplexes and polyplexes with CS for fraction of polyplex overlap-
pingwithmarkerwas 0.258 and0.502 respectively). Therefore, it is pos-
sible that the coated polyplexes taken up by caveolar endocytosis are
trafﬁcked to the Golgi network before entry into the nucleus.
4. Discussion
Peptide-based gene carriers possess numerous advantages over
other chemical vectors such as polymers and liposomes with respect
to safety, sequence diversity and functionalization. Yet, peptide carriers
have not found widespread clinical application mainly due to their low
efﬁciency in achieving therapeutic levels of transgene expression.
Therefore, their extensive use as gene delivery agents will beneﬁt
from designing of novel strategies to improve the efﬁciencies of current
peptide vectors. There are few reports in the literature where attach-
ment of polysaccharides, speciﬁcally sulfated GAGs like chondroitin sul-
fate, to polymers such as polyethylenimine [41] and chitosan [42] has
been observed to improve their gene delivery and targeting efﬁciency[43]. However, the effect of exogenous GAG addition on the gene deliv-
ery efﬁciency of peptide carriers has not been studied in detail.
Our group had ﬁrst reported that small amounts of exogenous GAGs
added to homoarginine (R16) polyplexes increased their transfection ef-
ﬁciency considerably in both wild-type and GAG-deﬁcient CHO cell
lines [12]. The GAGs enhanced the stability of the polyplexes and
protected the compacted DNA from nucleases. The polyplexes also
showed more efﬁcient cellular entry in the presence of GAGs than the
native polyplexes. Atomic force microscopy studies had revealed an in-
crease in size of the polyplexes on GAG addition. This was further con-
ﬁrmed using dynamic light scattering. The hydrodynamic diameters of
the native R16 polyplexes (67.14 ± 0.86 nm) increase by about 20 nm
on addition of GAGs at GAG:peptide w/w ratio of 0.5:1 (88.47 ±
0.14 nm). These results implied that the GAG possibly formed a ‘GAG
coat’ by electrostatic interactions at the polyplex surface. A similar phe-
nomenonwas also observedwith arginine-rich peptides containing dif-
ferent distributions of the positive residues, for example, 32 AR peptide,
containing a GAG-binding motif with clustered arginine residues sepa-
rated by neutral amino acids [23].
These observations pointed towards a hitherto unexplored role of
GAGs in gene delivery mediated by peptides. Several intriguing ques-
tions stemmed from this unusual observation, the most pertinent
being whether the presence of GAGs affects the mechanisms of cellular
uptake, intracellular processing and localization and if so, whether such
events affect the overall transfection efﬁciency. In the present study, we
initially conﬁrmed that the addition of exogenous CS improved the
Fig. 6. Effect of different endocytic inhibitors on gene delivery efﬁciency of R16 polyplexeswith andwithout exogenous chondroitin sulfate. A–D, Cells were pretreatedwith the respective
inhibitors for 1 h before addition of R16 polyplexes at Z(+/−) 10.0with orwithout exogenous CS at GAG:peptide w/w ratio of 0.5:1. Incubation was carried out for 5 h at 37 °C, and trans-
fection efﬁciencywasmeasured from luciferase activity after 24 h. Values are given asmean± S.D. of three independent experiments, each in duplicate (***p b 0.005, **p b 0.01, *p b 0.05).
Cpz, chlorpromazine; Gst, genistein; Dma, dimethylamiloride; CtcD, cytochalasin D; Ncd, nocodazole.
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AR, in multiple cell types, with different cell surface GAG compositions
including a HS-deﬁcient CHO mutant cell line, pgsD-677 which has CS
as the major cell surface GAG species (Fig. 1). We also observed that
even in the presence of serum the transfection efﬁciency of the
CS-coated R16 polyplexes was higher than that observed with uncoated
polyplexes in CHO-K1 cells (Fig. S5 in Supplemental information). This
illustrated that the addition of exogenous GAGs to polyplexes of
arginine-rich peptides can be used as a potential method to improve
the gene delivery efﬁciency in different cell types and can also be
extended for in vivo applications including dermal and ocular gene de-
livery. It also conﬁrmed our previous observations that arginine-rich
polyplexes, either with contiguous or spaced residues, enter cells inde-
pendent of the cell surface GAGs.
We also observed that there is an increase in cellular uptake in the
presence of small amounts of exogenous CS. We attempted to decipher
whether this could be because of differences in the uptake routes of the
native and CS-coated polyplexes. Elucidation of the uptake route was
also important because although CS coating causes enhanced cellular
uptake in all the cell lines, the extent of increase in transfection efﬁcien-
cy was different in different cell lines. Using chemical inhibitors for the
commonly observed endocytic uptake routes, we found that both the
wild-type and GAG-deﬁcient CHO cells took up the native R16
polyplexes bymultiple pathways including caveolae-mediated endocy-
tosis and macropinocytosis, whereas the CS-coated polyplexes were
predominantly taken up by the caveolar pathway (Fig. 3; large format
views given in Supplemental Fig. S9). Caveolae-mediated endocytosis
has also been reported to be functional in the uptake of other chemical
carriers including lipoplex and chitosan in CHO-K1 cells [44,45]. Also,
macropinocytic entry of arginine-rich peptides is well-documented
[13,46,47].
Using positive markers for the pathways of clathrin- and caveolin-
mediated endocytosis, we could however observe their co-localizationwith both the native or CS-coated polyplexes (Fig. 3B–C). This was
also conﬁrmed by immunostaining using antibodies against clathrin
and caveolin (Fig. 4). Therefore, looking at the effects of both chemical
inhibitors and the positive markers for the endocytic pathways in total-
ity, it seemed most likely that both the R16 and 32 AR polyplexes were
taken up by multiple pathways in CHO cells, regardless of the presence
or absence of exogenous CS. The presence of multiple uptake pathways
might also be responsible for the discrepancy observed between the
magnitude of increase in the cellular uptake and transfection of R16
polyplexes in the presence of CS amongst different cell lines (Fig. 1),
where all the pathways may not equally contribute to the ultimate
level of gene expression. A complete investigation of the kinetics of
entry of the polyplexes will therefore help in elucidating the exact
time course of intracellular events and the role of a particular pathway
in contributing to successful gene delivery ultimately.
The caveolae-mediated uptake of the R16 polyplexes was also found
to largely contribute to the ultimate levels of gene expression in the
CHO cell lines, since treatment with genistein decreased the transfec-
tion efﬁciency of both the native and CS coated polyplexes considerably
(Fig. 6). Treatment with chlorpromazine caused stimulation in the
transfection efﬁciency of R16 polyplexes in CHO cell lines, which was
also observed in the cellular uptake studies. This phenomenon has
been seen earlier also [48–50] and it is believed that inhibition of
clathrin dependent endocytosis by chlorpromazine may enhance up-
take by other pathways.
However, treatment with the inhibitors of the cytoskeletal network
like cytochalasin D and nocodazole showed conﬂicting results in the
pattern of uptake and corresponding transfection studies in the CHO
cell lines. Presence of these inhibitors reduced the uptake of the native
polyplexes whereas the uptake of the polyplexes with CS was either
not affected or increased. Hence, our results indicate that the cytoskele-
tal network constituted by actin ﬁlaments and microtubules plays a
major role in the uptake of the native arginine polyplexes, whereas its
Fig. 7. Endosomal escape of R16 polyplexes in the presence and absence of exogenous chondroitin sulfate. A, Cells were incubated with R16 polyplexes (with rhodamine-labeled DNA at
Z(+/−) 10.0) with or without CS (at GAG:peptide w/w of 0.5:1) and incubated for 2 h at 37 °C. LysoTracker Green DND-26 (150 nM) was added during ﬁnal 5 min of incubation.
Cells were washed and imaged with a laser scanning confocal microscope. Scale bar = 10 μm. B, Cells were incubated with R16 polyplexes (at Z(+/−) 10.0), with and without CS (at
GAG:peptide w/w 0.5:1) along with chloroquine (100 μM) and baﬁlomycin A1 (100 nM) for 5 h at 37 °C. Transfection efﬁciency was measured after 24 h from luciferase activity. Values
are plotted as mean ± S.D. of three independent experiments, each in duplicate (***p b 0.005, **p b 0.01, *p b 0.05). C, CHO-K1 cells were treated with R16 polyplexes (with rhodamine-
labeledDNA at Z(+/−) 10.0)with orwithout CS (atGAG:peptidew/wof 0.5:1) for 1 h at 37 °C, thenﬁxed, permeabilized and treatedwith primary antibody against giantin for 2 h at room
temperature. Cells were then incubated with Alexa Fluor 488-labeled secondary antibody for 2 h, washed and imaged with a confocal microscope. Scale bar = 20 μm.
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polyplexes. Yet, co-localization of either polyplexes with the actin ﬁla-
ments could not be observed (Fig. S2). Since the actin ﬁlaments andmi-
crotubules are known to be active in the various endocytic entry
mechanisms and are also required for vesicle transport intracellularly
[51–53], the mechanism of entry of the CS-coated polyplexes indepen-
dent of the cytoskeleton is rather intriguing, as also is its role in the up-
take of the native R16 polyplexes. But cytochalasin treatment reduced
the transfection efﬁciency of both the native and the CS-coated
polyplexes implying that actin polymerization may play a more impor-
tant role in the subsequent intracellular processing of both the
polyplexes. On the other hand, nocodazole treatment increased the
transfection efﬁciency in most cases. Nocodazole is known to inhibit
endosomal maturation by disrupting the microtubules, and therefore
polyplexes might be able to escape the lysosomal degradation leading
to better transfection efﬁciency in the presence of this drug [54,55].
We also analyzed whether the presence of the GAG coat which
helped in stabilization of the polyplexes and caused changes in the in-
tracellular routing was actually retained during the cellular entry andintracellular events. We observed greater accumulation of the polyplex
around the nuclear periphery in the presence of CS than in the case of
the native polyplexes after 4 h of incubation for both the peptides
studied (Figs. 2 and 5A); thereby conﬁrming the increased cellular up-
take seen earlier for the polyplexes with CS. We also observed co-
localization of CS-coated R16 polyplexeswith a Golgimarker, giantin, in-
dicating their trafﬁcking to the Golgi network (Fig. 7C). Subsequently, to
elucidate the localization of the polyplexes around the nucleus, we
checked for the co-localization of the R16 polyplexes with ER-Tracker
Green which stains the endoplasmic reticulum and with FM 4–64
which stains vesicular structures (Figs. S6 and S7 respectively in Supple-
mental information). However, no co-localization was observed under
these conditions; hence, the polyplexesweremost probably in the cyto-
sol fromwhere they could gain nuclear access. Nevertheless, our results
indicated that in all the cell lines used here, the CS coat remained asso-
ciated to the polyplex. Thus, clearly the GAGs are carried alongwith the
polyplexes and their presence might be conferring both extracellular
stability and aid in intracellular accumulation. Sandgren et al. had earlier
demonstrated that the protein transduction domain of HIV Tat could
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the nucleus [56]. Our observation not only corroborates this but also
goes one step further to demonstrate that this happens in arginine-
rich peptides in different cell types even when they are complexed
with nucleic acids.
Since most of the endocytic uptake routes involve endosome
maturation and fusion with lysosome, we also studied the intracellular
trafﬁcking of the polyplexes after their cellular entry. We observed
that both the native and coated R16 polyplexes co-localized with the
lysosomes to some extent. This was checked both at 2 h incubation
and 4 h incubation, the latter being the time point atwhich the transfec-
tion efﬁciency was measured (Fig. 7A and Fig. S8 (Supplemental
information)). At the longer time point, the amount of co-localization
of the coated R16 polyplex with the lysosomal marker was reduced
(as seen from lower Mander's coefﬁcient of co-localization in Fig. S8),
while the co-localization of the native polyplex remained same. In
view of the fact that lysosomal localization resulted in degradation of
the polyplexes, it was important to determine how the polyplexes coat-
ed with GAGs could accumulate in large quantities at the nuclear pe-
riphery and also lead to enhanced transfection efﬁciency. For this, we
examined the transfection efﬁciencies of the native and CS-coated R16
polyplexes in the presence of endosomal disruption agents such as chlo-
roquine and baﬁlomycin. Chloroquine treatment increased the transfec-
tion efﬁciency of the native polyplexes by an order of magnitude while
the effect on the CS-coated polyplexes was much smaller (Fig. 7B). In
addition, baﬁlomycin treatment reduced the transfection efﬁciency of
the CS-coated polyplexes to a larger extent than the native polyplexes.
These results implied that although the polyplexes indeed got
entrapped in the endosomes, the CS coat helped in efﬁcient endosomal
escape. Yet, the mechanism by which CS can aid endosomal escape is
not clear and would be an interesting prospect to explore.
In summary, we demonstrated that addition of small amounts of ex-
ogenous GAGs to polyplexes of arginine-rich peptides improved their
efﬁciency of overcoming the various hurdles faced during the process
of gene delivery.We have shown that the exogenous GAGs remain asso-
ciated with the polyplexes during their entire journey by forming a ter-
nary complex with the polyplex, or possibly by forming a ‘GAG coat’ on
their surface. This association enhanced the stability of the arginine-rich
polyplexes and offered better protection against nucleases in vitro [12].
The GAG-coated polyplexes also showed better cellular association and
cell entry than the native polyplexes. Irrespective of the multiple
endocytic routes that could be adopted, the presence of GAGs helped
the polyplexes to escape the endosomes more efﬁciently and accumu-
late at the nuclear periphery. Hence, we demonstrated the potential
applicability of addition of exogenous GAGs to arginine-based peptide
carriers as a paradigm to improve their gene delivery efﬁciencywithout
the need for chemical conjugation.
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